Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others ) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

  • Published On : Aug 2019 |
  • Pages : 167 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Bioactive Peptide Market – Market Insight

Bioactive peptides are amino acids combined together through a covalent bond. Bioactive peptides are extracted from various natural sources, thereby providing a variety of health benefits such as better cardiovascular, digestive, endocrine functioning, as well as the immune and nervous system. They are also used in protecting important contents of food and beverages, resulting in decreased oxidation and degradation of the products. Although these peptides are extracted from natural sources, some of them have been designed with the help of chemical synthesis.

Furthermore, bioactive peptides, as well as bioactive proteins are part of a balanced diet. The prominent factor driving the market demand is increasing incidence of chronic diseases, and growing geriatric population. Moreover, growing interest in bioactive peptides is driving the scientific community and the food industry to develop new food additives and functional products based on bioactive peptides.

The global bioactive peptide market size was valued at US$ 3,265.2 Mn in 2017, and is expected to exhibit a CAGR of 9.4% over the forecast period (2018–2026).

Figure 1. Global Bioactive Peptide Market Value (US$ Mn), by Region, 2018

Bioactive Peptide  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing incidence of chronic diseases such as diabetes, cancer, cardiovascular disease, chronic obstructive pulmonary disease (COPD), and others is propelling the global bioactive peptide market growth.

Increasing incidence of diseases like diabetes, cancer, and respiratory disorders is expected to drive growth of the global bioactive peptide market. According to the International Federation of Diabetes, 2017 report, around 425 million adults were suffering from diabetes globally, and the number is expected to reach 629 million by 2045.

According to a press release on September 2018 by the International Agency for Research on Cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, 1 in 5 men, and 1 in 6 women worldwide develop cancer during their lifetime, and 1 in 8 men, and 1 in 11 women die from the disease.

According to World Health Organization, 2017 statistics, an estimated 3.17 million incidences of chronic obstructive pulmonary disease (COPD) were recorded in 2015, which is COPD accounted for 5% of deaths globally in 2015. More than 90% of COPD incidences occur in low and middle income countries.

Innovations and products launches by market players is expected to drive growth of the bioactive peptides market during the forecast period. In November 2018, Nuritas Ltd., announced the commercial launch of Peptide which contains anti-inflammatory bioactive peptides. It was the first bioactive ingredient discovered and delivered through artificial intelligence.

Figure 2. Global Bioactive peptide Market Share (%), by Therapeutic Area

Bioactive Peptide  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Growing Demand for nutritional supplements

There has been increasing awareness among the populace regarding disease conditions, owing to initiatives and campaigns by government organizations, and increasing healthcare spending by government organizations are projected to drive growth of the global bioactive peptide market. According to Council for Responsible Nutrition (CRN) Washington, October 2018, Consumer Survey on Dietary Supplements, conducted by Ipsos Public Affairs found that 75% of U.S. adults take dietary supplements in 2018, compared to 65% in 2009.

Furthermore, strategic collaborations between market players for development of innovative products is expected to facilitate demand for bioactive peptides. For instance, in December 2018, Nestle and Nuritas Ltd. collaborated to discover food derived bioactive peptides.

Key Players

Major players operating in the global bioactive peptides market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy among others.

The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides used as treatment therapy for most of the functional disorders such as irritable bowel disease is expected to enhance the market growth.

Market Dynamics

Technological innovations and developments in extraction techniques of bioactive peptide from natural sources is contributing to the market growth. For instance, an article was published in the journal of 'Critical reviews in environmental science and technology' in June 2019, regarding recent developments in native bioactive peptides targeting informatics, novel microbial protease mining, and screening methods, which are expected to accelerate development of genome-based microbial routes to therapeutic bioactive peptides, that promote human health and nutrition. As a result, technological advancements and genetically modified products is expected to propel the growth of the bioactive peptide market.

Key features of the study:

  • This report provides in-depth analysis of the global bioactive peptide market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
  • It provides key players in the global bioactive peptide market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy and others.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global bioactive peptide market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioactive peptide market

Detailed Segmentation:

  • Global Bioactive Peptide Market, By Source:
    • Plant
    • Milk
    • Eggs
    • Meat
    • Fish
  • Global Bioactive Peptide Market, By Therapeutic Area:
    • Antihypertensive
    • Antioxidant
    • Immunostimulatory
    • Antimicrobial
    • Diabetes
    • Others
  • Global Bioactive Peptide Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Bioactive Peptide Market, By Region:
    • North America
      • By Source:
        • Plant
        • Milk
        • Eggs
        • Meat
        • Fish
      • By Therapeutic Area:
        • Antihypertensive
        • Antioxidant
        • Immunostimulatory
        • Antimicrobial
        • Diabetes
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Source:
        • Plant
        • Milk
        • Eggs
        • Meat
        • Fish
      • By Therapeutic Area:
        • Antihypertensive
        • Antioxidant
        • Immunostimulatory
        • Antimicrobial
        • Diabetes
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Source:
        • Plant
        • Milk
        • Eggs
        • Meat
        • Fish
      • By Therapeutic Area:
        • Antihypertensive
        • Antioxidant
        • Immunostimulatory
        • Antimicrobial
        • Diabetes
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Source:
        • Plant
        • Milk
        • Eggs
        • Meat
        • Fish
      • By Therapeutic Area:
        • Antihypertensive
        • Antioxidant
        • Immunostimulatory
        • Antimicrobial
        • Diabetes
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Source:
        • Plant
        • Milk
        • Eggs
        • Meat
        • Fish
      • By Therapeutic Area:
        • Antihypertensive
        • Antioxidant
        • Immunostimulatory
        • Antimicrobial
        • Diabetes
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Source:
        • Plant
        • Milk
        • Eggs
        • Meat
        • Fish
      • By Therapeutic Area:
        • Antihypertensive
        • Antioxidant
        • Immunostimulatory
        • Antimicrobial
        • Diabetes
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Archer Daniels Midland Company*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Seagarden AS
    • Phermpep Co. Ltd.
    • Arlak Biotech Pvt. Ltd.
    • Naturade
    • Royal DSMConsort Medical plc
    • MYOS RENS Technology Inc.
    • Natural Factors Inc.
    • Valio Oy
    • Others
  •  

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Source
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • Market Potential in Lower economies
  1. Global Bioactive peptide Market, By Source, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Plant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Milk
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Eggs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Meat
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Fish
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  1. Global Bioactive peptide Market, By Therapeutic Area, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Antihypertensive
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Antioxidant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Immunostimulatory 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Antimicrobial
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  1. Global Bioactive peptide Market, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trend
    • Hospital Pharmacies
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacies
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    •  Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  2. Global Bioactive Peptide Market, By Region, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Source, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Source, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Source, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Source, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Source, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Source, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  3. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Archer Daniels Midland Company*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Seagarden AS
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Phermpep Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Arlak Biotech Pvt. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Naturade
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Royal DSM
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MYOS RENS Technology Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Natural Factors Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Valio Oy
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  4. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 30 figures on "Bioactive Peptide Market” - Global forecast to 2026.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.